about
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesAnimal models for influenza virus pathogenesis, transmission, and immunologyMultivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and miceEvaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunizationPandemic and seasonal influenza: therapeutic challengesNew pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.Animal models in influenza vaccine testing.Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx moriPathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus sheddingCurrent status and progress of prepandemic and pandemic influenza vaccine development.Avian influenza: the threat of the 21st century.Animal models for the preclinical evaluation of candidate influenza vaccines.A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.The ferret as a model organism to study influenza A virus infection.Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models.Immunogenic and protective properties of the first Kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in ferrets.Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement.Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets.Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1.Animal models for the study of influenza pathogenesis and therapy.Baculovirus vector as a delivery vehicle for influenza vaccines.Animal models in virus research: their utility and limitations.Genetic characteristics of highly pathogenic H5N8 avian influenza viruses isolated from migratory wild birds in South Korea during 2014-2015.Control versus no control: options for avian influenza H5N1 in Nigeria.
P2860
Q24649949-63FBB31D-ADBE-4B2A-8F50-FBB1438F9612Q27024582-6371413A-9126-44CC-931E-4C43E8A35606Q27301043-3F8ED4F0-9A89-4A1A-BCF0-9A2A5A3BE2C9Q30227975-A364FDBD-3592-4822-8AEE-C8D0F0105029Q30228856-D87583C3-70EC-407F-88E9-FFA5CB580A69Q30365380-B0992448-2729-44D7-9AC2-6ACB3F22FD6FQ30371058-91B10A8B-48AC-4532-B43B-1F019011489FQ30373913-A4527AE8-DF62-4C64-88B8-DCF421B36366Q30374356-3805D33F-11F3-454C-BE76-8984B7047DA2Q30375975-4000EB66-6E77-496A-9C33-64C43F33CB9CQ30378353-35D5FD76-4CB9-4FE0-A7C8-BE24FA189CC6Q30383623-1F926BA4-72E1-4C3E-951D-902B21ECE674Q30385570-5B1DFF57-C3FC-46D0-B48B-210A5A8FA5A8Q30392828-E912EA90-D92F-4067-8514-F1735AB5ED55Q30405589-F98621AC-F45E-4F19-848F-4F71E99FD917Q30415387-1610C096-422D-4E3D-A7E2-F76765BEC23CQ30418752-FFCF9932-1557-4C76-AB97-71CFD89C49EAQ30424002-569EDC7C-3D30-4CC3-BBA4-43DDB2769E10Q30427798-A5B6CDA3-5413-46B0-AE35-158EB213307EQ36408162-6E963B26-F84D-4B2D-814F-5266AC28C58FQ36483949-AFAE7045-02CA-45DB-8D47-5EE39F1D4789Q36489533-66AC9835-8812-477E-8A03-FBE11247D159Q37001633-33F0A620-7BFA-4E30-B926-CCF94A1EE5E2Q37379466-56E1DBD0-599D-45AE-82CC-B335240BBD0AQ37434539-1DC63965-2D60-4AC1-B59C-01318C076310Q38043556-33E033C7-1EEB-4967-9F47-86CB1B1CABCDQ40647938-24586E40-572E-42A6-89B9-C9911C083317Q43222625-3C51CFC0-C54A-43B2-85B7-FE11BFA77C63
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
H5N1 viruses and vaccines
@ast
H5N1 viruses and vaccines
@en
H5N1 viruses and vaccines
@en-gb
H5N1 viruses and vaccines
@nl
type
label
H5N1 viruses and vaccines
@ast
H5N1 viruses and vaccines
@en
H5N1 viruses and vaccines
@en-gb
H5N1 viruses and vaccines
@nl
altLabel
H5N1 Viruses and Vaccines
@en
prefLabel
H5N1 viruses and vaccines
@ast
H5N1 viruses and vaccines
@en
H5N1 viruses and vaccines
@en-gb
H5N1 viruses and vaccines
@nl
P2860
P31
P921
P1433
P1476
H5N1 viruses and vaccines
@en
P2093
Catherine Luke
P275
P2860
P356
10.1371/JOURNAL.PPAT.0030040
P407
P5008
P577
2007-03-01T00:00:00Z